查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1191390

生化防御的全球市场(2023年～2033年)

Biodefence Market Report 2023-2033
出版日期: | 出版商: Visiongain | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

全球生化防御的市场规模，至2033年预计以7.78％的年复合成长率成长。先进各国的研究开发投资增加，已开发国家及初步开发经济各国对生物恐怖行动攻击相关意识的高涨，预计显着促进生化防御市场成长。

本报告提供全球生化防御市场的相关调查，市场概要，市场分析，企业简介等全面性资讯。

目录

第1章 报告概要

第2章 摘要整理

第3章 市场概要

  • 主要调查结果
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 市场机会
  • COVID-19影响分析
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 竞争企业间的敌对关係
    • 替代品的威胁
    • 新加入业者的威胁
  • PEST分析

第4章 生化防御市场分析:各产品

  • 主要调查结果
  • 产品市场区隔:市场魅力指数
  • 生化防御市场规模的估计与预测:各产品
  • 疫苗
    • 炭疽菌
    • 天花
    • 肉毒桿菌症
    • 其他
  • 生物威胁检测设备
    • 化验和试剂
    • 检测器
    • 鑑别器
    • 采样器

第5章 生化防御市场分析:各地区

  • 主要调查结果
  • 地区市场区隔:市场魅力指数
  • 生化防御市场规模的估计与预测

第6章 北美的生化防御市场分析

第7章 欧洲的生化防御市场分析

第8章 亚太地区的生化防御市场分析

第9章 南美的生化防御市场分析

第10章 中东及非洲的生化防御市场分析

第11章 企业简介

  • 竞争情形(2021年)
  • Alexeter Technologies, LLC,
  • Altimmune
  • ANP Technology
  • Bavarian Nordic
  • Biofire Defense(bioMerieux SA)
  • Biosearch Technologies
  • Bruker
  • Electronic Sensor Technology Inc.
  • Elusys Therapeutics
  • Emergent BioSolutions Inc.
  • Ichor Medical
  • NanoLogix
  • New Horizons Diagnostic Corporation
  • PositiveID Corporation
  • SIGA Technologies, Inc
  • Alnylam Pharmaceuticals
  • BBI Detection
  • Statera Biopharma
  • Dynport Vaccine Company
  • Research International
  • Smith's Detection
  • Synexis Systems

第12章 结论与建议

  • 结束
  • 对市场相关人员的推荐事项
Product Code: PHA1214

The global Biodefence market is projected to grow at a CAGR of 7.78% by 2033.

“The Biodefence Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing R&D Investments in Developed Countries

Growing R&D investments enable pharmaceutical and biopharmaceutical companies to manufacture superior quality and technologically advanced bio-threat detection devices that should significantly impact the industry growth. Furthermore, European government also supports the R&D activities to manufacture vaccines against various diseases such as anthrax, small pox and botulism in large batches to fight infections and prevent the spread of endemic diseases. Bioterrorism attacks lead to deaths and may weaken the economy hence, government funds various pharmaceutical as well as biopharmaceutical companies that will elevate the industry growth in foreseeable future.

Increasing Awareness Regarding Bioterrorism Attacks to Propel Industry Growth

Increasing awareness regarding bioterrorism attacks in developed as well as underdeveloped economies will significantly fuel the biodefence market growth over the forecast period. Owing to the advent of internet and growing adoption of social media, news about the biological warfare in any part of the world can spread across the globe. It can cause anxiety to people located faraway and can greatly impact trade and travel. Governments in the developing countries such as Japan and India plan public awareness campaigns to raise public awareness about bioterrorism attacks. Such preventive measures undertaken by the government to combat various endemic diseases will boost industry growth in the foreseeable future.

Low Government Funding in Underdeveloped Regions Likely to Challenge Market Growth

Minimal government intervention and low R&D funding in underdeveloped regions will impede the biodefence market growth over the forecast period. Furthermore, due to poor economic development, governments and regulatory authorities in countries such as Mexico and Brazil are unable to make significant investments to promote the use of biothreat detection devices. There is a lack of awareness in developing regions about the availability of technologically advanced biothreat detection devices. Additionally, there is no established regulatory framework for biodefence devices and vaccines in underdeveloped economies. Key players that operate in the biodefence industry find it difficult to enter these countries due to changing trade policies. As a result, the distribution of tools and vaccinations used to combat bioterrorism is low in emerging regions which may hamper the Biodefence market growth.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Biodefence Market evolving?
  • What is driving and restraining the Biodefence Market?
  • How will each Biodefence submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each Biodefence submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading Biodefence Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Biodefence development projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of Biodefence development projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Biodefence Market?
  • Where is the Biodefence Market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Biodefence Market today, and over the next 10 years:

  • Our 197-page report provides 112 tables and 107 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Biodefence Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of bio-threat detection devices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

By Product

  • Vaccines
    • Anthrax
    • Small Pox
    • Botulism
    • Others
  • Biothreat detection devices
    • Assays and reagents
    • Detectors
    • Identifiers
    • Samplers

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Biodefence Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Alexeter Technologies, LLC,
  • Altimmune
  • Achaogen, Inc
  • Alnylam Pharmaceuticals
  • ANP Technology
  • Bavarian Nordic
  • BBI Detection
  • Biofire Defense (bioMerieux SA)
  • Biosearch Technologies
  • Bruker
  • Dynport Vaccine Company
  • Electronic Sensor Technology Inc
  • Elusys Therapeutics
  • Emergent BioSolutions Inc
  • Ichor Medical
  • NanoLogix
  • New Horizons Diagnostic Corporation
  • PositiveID Corporation
  • Research International
  • SIGA Technologies, Inc
  • Statera Biopharma (Cleveland Biolabs)
  • Smith's Detection
  • Synexis Systems

Overall world revenue for Biodefence Market, 2023 to 2033 in terms of value the market will surpass US$15,922 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biodefence Market, 2023 to 2033 report help you?

In summary, our 197-page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Biodefence Market, 2023 to 2033 Market, with forecasts for Type of Product, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the Biodefence Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles of the major companies involved in the Biodefence Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Biodefence Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Biodefence Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing R&D investments by the government
      • 3.2.1.2 Favourable government initiatives in emerging economies
      • 3.2.1.3 Technological developments in biotechnology sector in the developed countries
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Low R&D funding in underdeveloped regions
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Increasing list of bio-threat agents
      • 3.2.3.2 Development of advanced biotechnology products
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Biodefence Market Analysis by Product

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Biodefence Market Size Estimation and Forecast by Product
  • 4.4 Vaccines
    • 4.4.1 Anthrax
      • 4.4.1.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.4.1.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.2 Small Pox
      • 4.4.2.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.4.2.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.3 Botulism
      • 4.4.3.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.4 Others
      • 4.4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Biothreat detection devices
    • 4.5.1 Assays and reagents
      • 4.5.1.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.5.1.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.2 Detectors
      • 4.5.2.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.5.2.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.3 Identifiers
      • 4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.5.3.2 Market Share by Region, 2023 & 2033 (%)
    • 4.5.4 Samplers
      • 4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
      • 4.5.4.2 Market Share by Region, 2023 & 2033 (%)

5 Biodefence Market Analysis by Region

  • 5.1 Key Findings
  • 5.2 Regional Segment: Market Attractiveness Index
  • 5.3 Biodefence Market Size Estimation and Forecast

6 North America Biodefence Market Analysis

  • 6.1 Key Findings
  • 6.2 North America Biodefence Market Attractiveness Index
  • 6.3 North America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
  • 6.4 North America Biodefence Market Size Estimation and Forecast by Country
  • 6.5 North America Biodefence Market Size Estimation and Forecast by Product
  • 6.6 U.S. Biodefence Market Analysis
  • 6.7 Canada Biodefence Market Analysis

7 Europe Biodefence Market Analysis

  • 7.1 Key Findings
  • 7.2 Europe Biodefence Market Attractiveness Index
  • 7.3 Europe Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
  • 7.4 Europe Biodefence Market Size Estimation and Forecast by Country
  • 7.5 Europe Biodefence Market Size Estimation and Forecast by Product
  • 7.6 Germany Biodefence Market Analysis
  • 7.7 France Biodefence Market Analysis
  • 7.8 UK Biodefence Market Analysis
  • 7.9 Italy Biodefence Market Analysis
  • 7.10 Spain Biodefence Market Analysis
  • 7.11 Russia Biodefence Market Analysis
  • 7.12 Rest of Europe Biodefence Market Analysis

8 Asia Pacific Biodefence Market Analysis

  • 8.1 Key Findings
  • 8.2 Asia Pacific Biodefence Market Attractiveness Index
  • 8.3 Asia Pacific Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
  • 8.4 Asia Pacific Biodefence Market Size Estimation and Forecast by Country
  • 8.5 Asia Pacific Biodefence Market Size Estimation and Forecast by Product
  • 8.6 Japan Biodefence Market Analysis
  • 8.7 China Biodefence Market Analysis
  • 8.8 India Biodefence Market Analysis
  • 8.9 Australia Biodefence Market Analysis
  • 8.10 South Korea Biodefence Market Analysis
  • 8.11 Rest of Asia Pacific Biodefence Market Analysis

9 Latin America Biodefence Market Analysis

  • 9.1 Key Findings
  • 9.2 Latin America Biodefence Market Attractiveness Index
  • 9.3 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
  • 9.4 Latin America Biodefence Market Size Estimation and Forecast by Country
  • 9.5 Latin America Biodefence Market Size Estimation and Forecast by Product
  • 9.6 Brazil Biodefence Market Analysis
  • 9.7 Mexico Biodefence Market Analysis
  • 9.8 Rest of Latin America Biodefence Market Analysis

10 MEA Biodefence Market Analysis

  • 10.1 Key Findings
  • 10.2 MEA Biodefence Market Attractiveness Index
  • 10.3 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
  • 10.4 MEA Biodefence Market Size Estimation and Forecast by Country
  • 10.5 MEA Biodefence Market Size Estimation and Forecast by Product
  • 10.6 GCC Biodefence Market Analysis
  • 10.7 South Africa Biodefence Market Analysis
  • 10.8 Rest of MEA Biodefence Market Analysis

11 Company Profiles

  • 11.1 Competitive Landscape, 2021
    • 11.1.1 BioFire Defense
    • 11.1.2 Bruker Corporation
    • 11.1.3 Emergent BioSolutions
    • 11.1.4 Smiths detection
  • 11.2 Alexeter Technologies, LLC,
    • 11.2.1 Company Snapshot
    • 11.2.2 Company Overview
    • 11.2.3 Product Benchmarking
  • 11.3 Altimmune
    • 11.3.1 Company Snapshot
    • 11.3.2 Company Overview
    • 11.3.3 Financial Analysis
      • 11.3.3.1 Net Revenue, 2017-2021
      • 11.3.3.2 R&D, 2017-2021
    • 11.3.4 Product Benchmarking
  • 11.4 ANP Technology
    • 11.4.1 Company Snapshot
    • 11.4.2 Company Overview
    • 11.4.3 Product Benchmarking
  • 11.5 Bavarian Nordic
    • 11.5.1 Company Snapshot
    • 11.5.2 Company Overview
    • 11.5.3 Financial Analysis
      • 11.5.3.1 Net Revenue, 2017-2021
      • 11.5.3.2 R&D, 2017-2021
      • 11.5.3.3 Regional Market Shares, 2021
    • 11.5.4 Product Benchmarking
    • 11.5.5 Strategic Outlook
  • 11.6 Biofire Defense (bioMerieux SA)
    • 11.6.1 Company Snapshot
    • 11.6.2 Company Overview
    • 11.6.3 Financial Analysis
      • 11.6.3.1 Net Revenue, 2017-2021
      • 11.6.3.2 R&D, 2017-2021
      • 11.6.3.3 Regional Market Shares, 2021
    • 11.6.4 Product Benchmarking
    • 11.6.5 Strategic Outlook
  • 11.7 Biosearch Technologies
    • 11.7.1 Company Snapshot
    • 11.7.2 Company Overview
    • 11.7.3 Financial Analysis
      • 11.7.3.1 Net Revenue, 2017-2021
      • 11.7.3.2 Regional Market Shares, 2021
    • 11.7.4 Product Benchmarking
  • 11.8 Bruker
    • 11.8.1 Company Snapshot
    • 11.8.2 Company Overview
    • 11.8.3 Financial Analysis
      • 11.8.3.1 Net Revenue, 2017-2021
      • 11.8.3.2 R&D, 2017-2021
      • 11.8.3.3 Regional Market Shares, 2021
    • 11.8.4 Product Benchmarking
  • 11.9 Electronic Sensor Technology Inc.
    • 11.9.1 Company Snapshot
    • 11.9.2 Company Overview
    • 11.9.3 Product Benchmarking
  • 11.10 Elusys Therapeutics
    • 11.10.1 Company Snapshot
    • 11.10.2 Company Overview
    • 11.10.3 Product Benchmarking
    • 11.10.4 Strategic Outlook
  • 11.11 Emergent BioSolutions Inc.
    • 11.11.1 Company Snapshot
    • 11.11.2 Company Overview
    • 11.11.3 Financial Analysis
      • 11.11.3.1 Net Revenue, 2017-2021
      • 11.11.3.2 R&D, 2017-2021
    • 11.11.4 Product Benchmarking
    • 11.11.5 Strategic Outlook
  • 11.12 Ichor Medical
    • 11.12.1 Company Snapshot
    • 11.12.2 Company Overview
    • 11.12.3 Product Benchmarking
  • 11.13 NanoLogix
    • 11.13.1 Company Snapshot
    • 11.13.2 Company Overview
    • 11.13.3 Product Benchmarking
  • 11.14 New Horizons Diagnostic Corporation
    • 11.14.1 Company Snapshot
    • 11.14.2 Company Overview
    • 11.14.3 Product Benchmarking
    • 11.14.4 Strategic Outlook
  • 11.15 PositiveID Corporation
    • 11.15.1 Company Snapshot
    • 11.15.2 Company Overview
    • 11.15.3 Product Benchmarking
  • 11.16 SIGA Technologies, Inc
    • 11.16.1 Company Snapshot
    • 11.16.2 Company Overview
    • 11.16.3 Financial Analysis
      • 11.16.3.1 Net Revenue, 2017-2021
      • 11.16.3.2 R&D, 2017-2021
    • 11.16.4 Product Benchmarking
    • 11.16.5 Strategic Outlook
  • 11.17 Alnylam Pharmaceuticals
    • 11.17.1 Company Snapshot
    • 11.17.2 Company Overview
    • 11.17.3 Financial Analysis
      • 11.17.3.1 Net Revenue, 2017-2021
      • 11.17.3.2 R&D, 2017-2021
    • 11.17.4 Product Benchmarking
    • 11.17.5 Strategic Outlook
  • 11.18 BBI Detection
    • 11.18.1 Company Snapshot
    • 11.18.2 Company Overview
    • 11.18.3 Product Benchmarking
  • 11.19 Statera Biopharma
    • 11.19.1 Company Snapshot
    • 11.19.2 Company Overview
    • 11.19.3 Financial Analysis
      • 11.19.3.1 Net Revenue, 2017-2021
      • 11.19.3.2 R&D, 2017-2021
    • 11.19.4 Product Benchmarking
  • 11.20 Dynport Vaccine Company
    • 11.20.1 Company Snapshot
    • 11.20.2 Company Overview
    • 11.20.3 Product Benchmarking
  • 11.21 Research International
    • 11.21.1 Company Snapshot
    • 11.21.2 Company Overview
    • 11.21.3 Product Benchmarking
  • 11.22 Smith's Detection
    • 11.22.1 Company Snapshot
    • 11.22.2 Company Overview
    • 11.22.3 Product Benchmarking
    • 11.22.4 Strategic Outlook
  • 11.23 Synexis Systems
    • 11.23.1 Company Snapshot
    • 11.23.2 Company Overview
    • 11.23.3 Product Benchmarking
    • 11.23.4 Strategic Outlook

12 Conclusion and Recommendations

  • 12.1 Concluding Remarks from
  • 12.2 Recommendations for Market Players

List of Tables

  • Table 1 Biodefence Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
  • Table 2 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Table 3 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "U" Shaped Recovery Scenario
  • Table 4 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "W" Shaped Recovery Scenario
  • Table 5 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "L" Shaped Recovery Scenario
  • Table 6 Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 7 Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 8 Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 9 Biodefence Market Forecast by Product, 2023-2033 (US$ million)
  • Table 10 Anthrax Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 11 Small Pox Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 12 Botulism Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 14 Assays and reagents Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 15 Detectors Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 16 Identifiers Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 17 Samplers Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 18 Biodefence Market Forecast by Region, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 19 North America Biodefence Market Forecast by Country
  • Table 20 North America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 21 North America Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 22 North America Biodefence Devices Market by Biothreat detection devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 23 U.S. Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 24 Canada Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 25 Europe Biodefence Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 26 Europe Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 27 Europe Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 28 Europe Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 29 Germany Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 30 France Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 31 UK Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 32 Italy Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 33 Spain Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 34 Russia Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 35 Rest of Europe Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 36 Asia Pacific Biodefence Market Forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 37 Asia Pacific Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 38 Asia Pacific Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 39 Asia Pacific Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR(%))
  • Table 40 Japan Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 41 China Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 42 India Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 43 Australia Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 44 South Korea Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 45 Rest of Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 46 Latin America Biodefence forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 47 Latin America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 48 Latin America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 49 Latin America Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 50 Brazil Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 51 Mexico Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 52 Rest of Latin America Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 53 MEA Biodefence forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 54 MEA Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 55 MEA Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 56 MEA Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
  • Table 57 GCC Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 58 South Africa Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 59 Rest of MEA Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
  • Table 60 Alexeter Technologies, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 61 Alexeter Technologies, LLC: Product Benchmarking
  • Table 62 Altimmune: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 63 Altimmune: Product Benchmarking
  • Table 64 ANP Technology: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 65 ANP Technology: Product Benchmarking
  • Table 66 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 67 Bavarian Nordic: Product Benchmarking
  • Table 68 Bavarian Nordic: Strategic Outlook
  • Table 69 Biofire Defense (bioMerieux SA): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 70 Biofire Defense (bioMerieux SA): Product Benchmarking
  • Table 71 Biofire Defense (bioMerieux SA.: Strategic Outlook
  • Table 72 Biosearch Technologies : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 73 Biosearch Technologies: Product Benchmarking
  • Table 74 Bruker: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 75 Bruker: Product Benchmarking
  • Table 76 Electronic Sensor Technology Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 Electronic Sensor Technology Inc .: Product Benchmarking
  • Table 78 Elusys Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Elusys Therapeutics .: Product Benchmarking
  • Table 80 Elusys Therapeutics : Strategic Outlook
  • Table 81 Emergent BioSolutions Inc.: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Emergent BioSolutions Inc.: Product Benchmarking
  • Table 83 Emergent BioSolutions Inc.: Strategic Outlook
  • Table 84 Ichor Medical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Ichor Medical: Product Benchmarking
  • Table 86 NanoLogix: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 NanoLogix: Product Benchmarking
  • Table 88 New Horizons Diagnostic Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 New Horizons Diagnostic Corporation: Product Benchmarking
  • Table 90 New Horizons Diagnostic Corporation: Strategic Outlook
  • Table 91 PositiveID Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 PositiveID Corporation .: Product Benchmarking
  • Table 93 SIGA Technologies, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 SIGA Technologies, Inc.: Product Benchmarking
  • Table 95 SIGA Technologies, Inc: Strategic Outlook
  • Table 96 Alnylam Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Alnylam Pharmaceuticals: Product Benchmarking
  • Table 98 Alnylam Pharmaceuticals: Strategic Outlook
  • Table 99 BBI Detection: Key Details, (CEO, HQ, Founded, No. of Employees, Business Segment)
  • Table 100 BBI Detection: Product Benchmarking
  • Table 101 Statera Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Statera Biopharma: Product Benchmarking
  • Table 103 Dynport Vaccine Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Dynport Vaccine Company: Product Benchmarking
  • Table 105 Research International: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Research International: Product Benchmarking
  • Table 107 Smith's Detection: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Smith's Detection : Product Benchmarking
  • Table 109 Smith's Detection: Strategic Outlook
  • Table 110 Synexis Systems: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Synexis Systems: Product Benchmarking
  • Table 112 Synexis Systems: Strategic Outlook

List of Figures

  • Figure 1 Biodefence Market Segmentation
  • Figure 2 Biodefence Market by Product: Market Attractiveness Index
  • Figure 3 Biodefence Market by Vaccines: Market Attractiveness Index
  • Figure 4 Biodefence Market by Product: Market Attractiveness Index
  • Figure 5 Biodefence Market Attractiveness Index by Region
  • Figure 6 Biodefence Market: Market Dynamics
  • Figure 7 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 8 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 9 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 10 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 11 Biodefence Market: Porter's Five Forces Analysis
  • Figure 12 Biodefence Market: PEST Analysis
  • Figure 13 Biodefence Market by Product: Market Attractiveness Index
  • Figure 14 Biodefence Market by Vaccines: Market Attractiveness Index
  • Figure 15 Biodefence Market by Product: Market Attractiveness Index
  • Figure 16 Biodefence Market Share Forecast by Product, 2023-2033 (%)
  • Figure 17 Anthrax Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 18 Anthrax Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 19 Small Pox Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 20 Small Pox Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 21 Botulism Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 22 Botulism Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 23 Others Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 24 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 25 Assays and reagents Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 26 Assays and reagents Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 27 Detectors Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 28 Detectors Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Identifiers Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 30 Identifiers Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Samplers Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 32 Samplers Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 33 Biodefence Market by Region: Market Attractiveness Index
  • Figure 34 Biodefence Market by Region, 2023-2033 (US$ Mn)
  • Figure 35 Biodefence Market Share Forecast by Region 2023, 2033(%)
  • Figure 36 North America Biodefence Market Attractiveness Index
  • Figure 37 North America Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 38 North America Biodefence Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 39 North America Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 40 North America Biodefence Market Forecast by Product, 2023-2033 (US$ million)
  • Figure 41 North America Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 42 U.S. Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 43 Canada Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 44 Europe Biodefence Market Attractiveness Index
  • Figure 45 Europe Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 46 Europe Biodefence Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 47 Europe Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 48 Europe Biodefence Market Forecast by Product, 2023-2033 (US$ million)
  • Figure 49 Europe Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 50 Germany Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 51 France Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 52 UK Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 53 Italy Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 54 Spain Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 55 Russia Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 56 Rest of Europe Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 57 Asia Pacific Biodefence Market Attractiveness Index
  • Figure 58 Asia Pacific Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 59 Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 60 Asia Pacific Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 61 Asia Pacific Biodefence Market Forecast by Product, 2023-2033 (US$ million, AGR %)
  • Figure 62 Asia Pacific Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 63 Japan Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 64 China Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 65 India Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 66 Australia Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 67 South Korea Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 68 Rest of Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 69 Latin America Biodefence Market Attractiveness Index
  • Figure 70 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ million)
  • Figure 71 Latin America Biodefence Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 72 Latin America Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 73 Latin America Biodefence Market Forecast by Product, 2023-2033 (US$ million)
  • Figure 74 Latin America Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 75 Brazil Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 76 Mexico Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 77 Rest of Latin America Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 78 MEA Biodefence Market Attractiveness Index
  • Figure 79 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ million)
  • Figure 80 MEA Biodefence Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 81 MEA Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 82 MEA Biodefence Market Forecast by Product, 2023-2033 (US$ million)
  • Figure 83 MEA Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 84 GCC Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 85 South Africa Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 86 Rest of MEA Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 87 Altimmune: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 88 Altimmune: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 89 Bavarian Nordic: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 90 Bavarian Nordic: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 91 Bavarian Nordic: Regional Market Shares, 2021
  • Figure 92 Biofire Defense (bioMerieux SA): Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 93 Biofire Defense (bioMerieux SA): R&D, 2017-2021 (US$ million, AGR%)
  • Figure 94 Biofire Defense (bioMerieux SA): Regional Market Shares, 2021
  • Figure 95 Biosearch Technologies: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 96 Biosearch Technologies.: Regional Market Shares, 2021
  • Figure 97 Bruker: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 98 Bruker: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 99 Bruker: Regional Market Shares, 2021
  • Figure 100 Emergent BioSolutions Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 101 Emergent BioSolutions Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 102 SIGA Technologies, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 103 SIGA Technologies, Inc.: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 104 Alnylam Pharmaceuticals: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 105 Alnylam Pharmaceuticals: R&D, 2017-2021 (US$ million, AGR%)
  • Figure 106 Statera Biopharma: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 107 Statera Biopharma : R&D, 2017-2021 (US$ million, AGR%)